Title : Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib.

Pub. Date : 2019 Mar

PMID : 30956968






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib. Dasatinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens